JP Morgan Maintains Neutral on Teladoc Health, Lowers Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Lisa Gill maintains a Neutral rating on Teladoc Health (NYSE:TDOC) but lowers the price target from $19 to $16.
May 21, 2024 | 4:20 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
JP Morgan analyst Lisa Gill maintains a Neutral rating on Teladoc Health but lowers the price target from $19 to $16.
The lowered price target from $19 to $16 by JP Morgan suggests a less optimistic outlook for Teladoc Health, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100